Iterum Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 Dec 23 | BuyUS$35,000 | Michael Dunne | Individual | 25,000 | US$1.40 | |
18 Dec 23 | BuyUS$18,442 | Michael Dunne | Individual | 10,000 | US$1.84 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 411,225 | 1.49% |
Institutions | 2,040,836 | 7.42% |
General Public | 25,063,865 | 91.1% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 110.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,340,000 | US$2.7m | 0% | 0.06% | |||
345,020 | US$707.3k | 255% | 0.59% | |||
224,750 | US$460.7k | 0% | 0.12% | |||
220,001 | US$451.0k | 93.4% | no data | |||
137,062 | US$281.0k | 152% | no data | |||
64,833 | US$132.9k | 0% | 0.03% | |||
33,040 | US$67.7k | 0% | no data | |||
18,839 | US$38.6k | 0% | no data | |||
14,947 | US$30.6k | 0% | no data | |||
14,346 | US$29.4k | 0% | no data | |||
12,370 | US$25.4k | 102% | no data | |||
10,369 | US$21.3k | 0% | no data | |||
8,135 | US$16.7k | 0% | no data | |||
5,479 | US$11.2k | 0% | no data | |||
2,473 | US$5.1k | 0% | no data | |||
133 | US$270.8 | 0% | no data | |||
85 | US$174.9 | -93.4% | no data | |||
66 | US$135.4 | 0% | no data | |||
66 | US$135.4 | 0% | no data | |||
40 | US$84.6 | 0% | no data | |||
13 | US$28.2 | 0% | no data | |||
3 | US$5.6 | 0% | no data | |||
2 | US$5.6 | 0% | no data | |||
1 | US$0 | 0% | no data | |||
1 | US$0 | 0% | no data |